Skip to main content
SpringerLink
Log in

Anti-suicidal Properties of Lithium Treatment

  • Reference work entry
  • First Online:
Suicide Risk Assessment and Prevention

  • 916 Accesses

Abstract

Lithium is one of the most incredible elements in the world. It is unique in many aspects. Despite its wide usage in manufacturing, it has been a proven, effective medication in psychiatry for decades. Its mood-stabilizing effects have led to its inclusion in national and international guidelines as a gold-standard in the treatment of both bipolar and unipolar affective disorder. Suicidality is one of the most challenging syndromes in mental illness. Its prevention and treatment options for healthcare providers are extremely important. Lithium’s anti-suicidal effects have been investigated in many international studies since the early 1990s. This effect was demonstrated by applying various designs, settings, and taking different statistical approaches including retrospective data analyses of suicides, suicide attempts, or suicidal behavior but also mortality data. Interestingly, this anti-suicidal effect has also been revealed in other research directions, i.e., the correlation between the lithium level in tap water and suicide rates. The following chapter provides a review of studies examining lithium’s anti-suicidal effects, discusses clinical implications, and offers a practical guide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 699.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alda M, Grof E, Cavazzoni P, et al. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis? J Affect Disord. 1997;44:153–7.

    Article  CAS  Google Scholar 

  2. Ahrens B, Müller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001;34:132–6.

    Article  CAS  Google Scholar 

  3. Ando S, Koike S, Shimodera S, Fujito R, Sawada K, Terao T, et al. Lithium levels in tap water and the mental health problems of adolescents: an individual-level cross-sectional survey. J Clin Psychiatry. 2017;78:e252–6. https://doi.org/10.4088/JCP.15m10220.

    Article  Google Scholar 

  4. Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch Suicide Res. 2005;9:279–300.

    Article  Google Scholar 

  5. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999;60(Suppl 2):77–84. discussion 111-116

    CAS  Google Scholar 

  6. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attemps during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8:625–39.

    Article  CAS  Google Scholar 

  7. Baldessarini RJ, Tondo L. Suicidal risks during treatment of bipolar disorder patients with Lithium versus anticonvulsants. Pharmacopsychiatry. 2009;42:72–5. https://doi.org/10.1055/s-0028-1103291.

    Article  CAS  Google Scholar 

  8. Baldessarini RJ, Vázquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020. https://doi.org/10.1186/s40345-019-0160-1.

  9. Barjasteh-Askari F, Davoudi M, Amini H, Ghorbani M, Yaseri M, Yunesian M, Mahvi AH, Lester D. Relationship between suicide mortality and lithium in drinking water: a systematic review and meta-analysis. J Affect Disord. 2020;264:234–41. https://doi.org/10.1016/j.jad.2019.12.027.

    Article  CAS  Google Scholar 

  10. Barraclough B. Suicide prevention, recurrent affective disorder and lithium. Br J Psychiatry. 1972;121:391–2.

    Article  CAS  Google Scholar 

  11. Bauer M, Gitlin M. Editors. The essential guide to lithium treatment. Cham: Springer; 2016.

    Book  Google Scholar 

  12. Bellivier F, Marie-Claire C. Molecular signatures of lithium treatment: current knowledge. Pharmacopsychiatry. 2018;51:212–9. https://doi.org/10.1055/a-0650-4820.

    Article  CAS  Google Scholar 

  13. Blüml V, Regier MD, Hlavin G, Rockett IR, König F, Vyssoki B, Bschor T, Kapusta ND. Lithium in the public water supply and suicide mortality in Texas. J Psychiatr Res. 2013;47:407–11.

    Article  Google Scholar 

  14. Bocchetta A, Ardau R, Burrai C, Chillotti C, Quesada G, Del Zompo M. Suicidal behaviour on and off lithium prophylaxis in a group of patients with prior suicide attemps. J Clin Psychopharmacol. 1998;18:384–9.

    Article  CAS  Google Scholar 

  15. Brodersen A, Licht RW, Vestergaard P, Olesen AV, Mortensen PB. Sixteen-year mortality in patients with affective disorder commenced on lithium. Br J Psychiatry. 2000;176:429–33.

    Article  CAS  Google Scholar 

  16. Brown EE, Gerretsen P, Pollock B, Graff-Guerrero A. Psychiatric benefits of lithium in water supplies may be due to protection from the neurotoxicity of lead exposure. Med Hypotheses. 2018;115:94–102. https://doi.org/10.1016/j.mehy.2018.04.005.

    Article  CAS  Google Scholar 

  17. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33:395–405.

    Article  CAS  Google Scholar 

  18. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013 27;346:f3646. https://doi.org/10.1136/bmj.f3646.

  19. Cleare A, Parianate CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressant: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29:459–525.

    Article  CAS  Google Scholar 

  20. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord. 2008;107:23–8.

    Article  CAS  Google Scholar 

  21. Comai S, Tau M, Pavlovic Z, Gobbi G. The pharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants and lithium. J Clin Psychopharmacol. 2012;32:237–60.

    Article  CAS  Google Scholar 

  22. Conell J, Just R, Felber W. Suizidale Handlungen in einer Kohorte 20-jähriger Lithiumbehandlungen. 3. Mitteldt. Psychiatrietage „Stand der Ursachen- und Therapieforschung bei psychischen Erkrankungen“, Abstract-Bd., Magdeburg, 16–17 März; 2001, S. 17.

    Google Scholar 

  23. Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, Gardner R, Maggs R. Prophylactic lithium in affective disorders. Controlled trial. Lancet. 1971;2:275–9.

    Article  CAS  Google Scholar 

  24. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord. 1991;23:1–7.

    Article  CAS  Google Scholar 

  25. Coryell W, Arndt S, Turvey C, Endicott J, Solomon D, Mueller T, Leon AC, Keller M. Lithium and suicidal behaviour in major affective disorder: a case-control study. Acta Psychiatr Scand. 2001;104:193–7.

    Article  CAS  Google Scholar 

  26. Diniz BSO, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat. 2013;9:493–500. https://doi.org/10.2147/NDT.S33086.

    Article  CAS  Google Scholar 

  27. Fieve RR. Clinical use of lithium in affective disorders. Drugs. 1977;13:458–66.

    Article  CAS  Google Scholar 

  28. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:409–17.

    Article  Google Scholar 

  29. Forlenza OV, De-Paula VJR, Diniz BSO. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5:443–50. https://doi.org/10.1021/cn5000309.

    Article  CAS  Google Scholar 

  30. Fülle M, Felber W, Israel M. Untersuchung zur Medikation im Vorfeld psychiatrischer Kliniksuizide. 3. Mitteldeutsche Psychiatrietage „Stand der Ursachen-und Therapieforschung bei psychischen Erkrankungen“, Magedeburg 16.-17.März 2001, Abstract-Bd., S. 14.

    Google Scholar 

  31. Giotakos O, Nisianakis P, Tsouvelas G, Giakalou VV. Lithium in the public water supply and suicide mortality in Greece. Biol Trace Elem Res. 2013;156:376–9.

    Article  CAS  Google Scholar 

  32. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467–73.

    Article  CAS  Google Scholar 

  33. Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord. 1996;40:179–90.

    Article  CAS  Google Scholar 

  34. Griffiths JJ, Zarate, Jr CA, Rasimas JJ. Existing and novel biological therapeutics in suicide prevention. Am J Prev Med. 2014;47:S195–S203. https://doi.org/10.1016/j.amepre.2014.06.012.

  35. Gysin-Maillart A, Schwab S, Soravia L, Schwab S, Soravia L, Megert M, Michel K. A novel brief therapy for patients who attempt suicide: a 24-months follow-up randomized controlled study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med. 2016;13:e1001968. https://doi.org/10.1371/journal.pmed.1001968.

    Article  Google Scholar 

  36. Hagnell O, Lanke J, Rorsman B. Suicide rates in the Lundby study: mental illness as a risk factor for suicide. Neuropsychobiology. 1981;7:248–53.

    Article  CAS  Google Scholar 

  37. Hajek T, Weiner MW. Neuroprotective effects of lithium in human brain? Food for thought. Alzheimer Res. 2016;13:862–72. https://doi.org/10.2174/1567205013666160219112712.

    Article  CAS  Google Scholar 

  38. Haußmann R, Mudra T, Sauer C, von Bonin S, Donix M, Bauer M, Lewitzka U. Analysis of risk factors, etiology and treatment standard of lithium poisoning. Nervenarzt. 2020;91:57–63. https://doi.org/10.1007/s00115-019-0705-7.

    Article  Google Scholar 

  39. Hui TP, Kandola A, Shen L, Lewis G, Osborn DPJ, Geddes JR, Hayes JF. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 2019;140:94–115.

    Article  CAS  Google Scholar 

  40. Isometsä E. Suicidal behaviour in mood disorders – who, when, and why? Can J Psychiatr. 2014;59:120–30.

    Article  Google Scholar 

  41. Kabacs N, Memon A, Obinwa T, Stochl J, Perez J. Lithium in drinking water and suicide rates across the east of England. Br J Psychiatry. 2011;198:406–7.

    Article  Google Scholar 

  42. Kapusta ND, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K. Lithium in drinking water and suicide mortality. Br J Psychiatry. 2011;198:346–50.

    Article  Google Scholar 

  43. Kay DWK, Petterson U. Mortality. In: Petterson U (eds) Manic depressive illness: a clinical, social and genetic study. Acta Psychiatrica Scandinavica 1977; (suppl 269):55–60.

    Google Scholar 

  44. Khan A, Khan SR, Hobus J, Faucett J, Mehra V, Giller EL, Rudolph RL. Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. J Psychiatr Res. 2011;45:1489–96.

    Article  Google Scholar 

  45. Kessing LV, Søndergård L, Kvist K, Andersen PK. Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005;62:860–6.

    Article  Google Scholar 

  46. Kleindienst N, Engel RR, Greil W. Psychosocial and demographic factors associated with response to prophylactic ltihium: a systematic review for bipolar disorders. Psychol Med. 2005;35:1685–94.

    Article  CAS  Google Scholar 

  47. Knudsen NN, Schullehner J, Hansen B, Jørgensen LF, Kristiansen SM, Voutchkova DD, et al. Lithium in drinking water and incidence of suicide: a nationwide individual-level cohort study with 22 years of follow-up. Public Health. 2017;14:627. https://doi.org/10.3390/ijerph14060627.

    Article  CAS  Google Scholar 

  48. Kugimiya T, Ishii N, Kohno K, Kanehisa M, Hatano K, Hirakawa H, Terao T. Lithium in drinking water and suicide prevention: the largest nationwide epidemiological study from Japan. Bipolar Disord. 2020. https://doi.org/10.1111/bdi.12983.

  49. Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand. 2008;118:469–79.

    Article  CAS  Google Scholar 

  50. Leith WM, Lambert WE, Boehnlein JK, Freeman MD. The association between gabapentin and suicidality in bipolar patients. Int Clin Psychopharmacol. 2019;34:27–32. https://doi.org/10.1097/YIC.0000000000000242.

    Article  Google Scholar 

  51. Lewitzka U, Jabs B, Fülle M, Holthoff V, Juckel G, Uhl I. Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode. BMC Psychiatry. 2015;15:117. https://doi.org/10.1186/s12888-015-0499-5.

    Article  CAS  Google Scholar 

  52. Liaugaudaite V, Naginiene R, Raskauskiene N, Mickuviene N, Bunevicius A, Sher L. Relationship between lithium levels in drinking water and suicide rates: a nationwide study in Lithuania. Arch Suicide Res. 2019;9:1–13. https://doi.org/10.1080/13811118.2019.1674226.

    Article  Google Scholar 

  53. Licht RW, Nielsen JN, Gram LF, Vestergaard P, Bendz H. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord. 2010;12:483–93.

    Article  CAS  Google Scholar 

  54. Lundquist G. Prognosis and cause of manic depressive psychosis. Acta Psychiatr Neurol Scand. 1945;35:1–96.

    Google Scholar 

  55. Malhi GS, Das P, Outhred T, Irwin L, Morris G, Hamilton A, Lynch K, Mannie Z. Understanding suicide: focusing on its mechanisms through a lithium lens. J Affect Disord. 2018;241:338–47. https://doi.org/10.1016/j.jad.2018.08.036.

    Article  CAS  Google Scholar 

  56. Memon A, Rogers I, Fitzsimmons SMDD, Carter B, Strawbridge R, Hidalgo-Mazzei D, Young AH. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies. Br J Psychiatry. 2020. https://doi.org/10.1192/bjp.2020.128.

  57. Moreira J, Geoffroy PA. Lithium and bipolar disorder: impacts from molecular to behavioural circadian rhythms. Chronobiol Int. 2016;33:351–73.

    Article  CAS  Google Scholar 

  58. Müller-Oerlinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology. 2010;62:43–9. https://doi.org/10.1159/000314309.

    Article  CAS  Google Scholar 

  59. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R, et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand. 1992a;86:218–22.

    Article  Google Scholar 

  60. Müller-Oerlinghausen B, Müser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord. 1992b;25:261–9.

    Google Scholar 

  61. Neuner T, Hübner-Liebermann B, Haen E, Hausner H, Felber W, Wittmann M, AGATE. Completed suicides in 47 hospitals in Germany – results from the AGATE-study. Pharmacopsychiatry. 2011;34:132–6.

    Google Scholar 

  62. National Institut for Health and Care Excellence (NICE) Bipolar Disorder. The mangemen of bipolar disorder in adults, children and adolescents, in primary and secondary care. London: NICE; 2006.

    Google Scholar 

  63. National Collaborating Centre for Mental Health (UK). Depressioni: the treatment and management of depression in adults, NICE clinical guidelines, no. 90. Leicester: British Psychological Society; 2010.

    Google Scholar 

  64. Nierenberg AA, Friedmann ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, et al. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry. 2013;170:102–10.

    Article  Google Scholar 

  65. Nolen WA, Weisler RH. The association oft he effect of ltihium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (trial 144). Bipolar Disord. 2013;15:100–9.

    Article  CAS  Google Scholar 

  66. Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, et al. ISBD/IGSLI Task Force on the treatment with lithium. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI task force on treatment with lithium. Bipolar Disord. 2019;21:394–409. https://doi.org/10.1111/bdi.12805.

    Article  CAS  Google Scholar 

  67. Ohgami H, Terao T, Shiotsuki I, Ishii N, Iwata N. Lithium levels in drinking water and risk of suicide. Br J Psychiatry. 2009;194:464–5.

    Article  Google Scholar 

  68. Oliveira P, Zagalo J, Madeira N, Neves O. Lithium in public drinking water and suicide mortality in Portugal: initial approach. Acta Medica Port. 2019;32:47–52. https://doi.org/10.20344/amp.10744.

    Article  CAS  Google Scholar 

  69. Oquendo MA, Galfalvy HC, Currier D, GRunebaum MF, Sher L, Sullivan GM. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry. 2011;168:1050–6. https://doi.org/10.1176/appi.ajp.2011.11010163.

    Article  Google Scholar 

  70. Palmer A, Cates ME, Gorman G. The association between lithium in drinking water and incidence of suicide across 15 Alabama counties. Crisis. 2019;40:93–9. https://doi.org/10.1027/0227-5910/a000535.

    Article  Google Scholar 

  71. Post RM. The new news about lithium: an underutilized treatment in the United States. Neuropsychopharmacology. 2018;43:1174–9.

    Article  CAS  Google Scholar 

  72. Prien RF, Klett CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry. 1973a;29:420–5.

    Article  CAS  Google Scholar 

  73. Prien RF, Caffey EM Jr, Klett CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry. 1973b;28:337–41.

    Google Scholar 

  74. Szklarska D, Rzymski P. Is lithium a micronutrient? From biological activity and epidemiological observation to food fortification. Biol Trace Elem Res. 2019;189:18–27. https://doi.org/10.1007/s12011-018-1455-2.

    Article  CAS  Google Scholar 

  75. Smith KA, Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord. 2017;19:575–86. https://doi.org/10.1111/bdi.12543.

    Article  CAS  Google Scholar 

  76. Tsuang MT, Woolson RF. Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry. 1978;35:1181–5.

    Article  CAS  Google Scholar 

  77. Vita A, De Peri L, Sacchetti E. Lithium in drinking water and suicide prevention: a review of the evidence. Int Clin Psychotpharmacol. 2015;30:1–5.

    Article  Google Scholar 

  78. Weeke A. Causes of death in manic depressives. In: Schou M, Strömgren E, editors. Origin, prevention and treatment of affective disorders. London: Academic Press; 1979. p. 289–99.

    Google Scholar 

  79. WHO 2000. Preventing suicide. A resource for general physicians. http://www.who.int/mental_health/media/en/56.pdf?ua=1. Accessed 25 Oct 2020.

  80. WHO 2013. Comprehensive mental health action plan 2013-2020-2030. https://www.who.int/mental_health/action_plan_2013/en/. Accessed 25 Oct 2020.

  81. WHO 2019. Suicide in the world: global health estimates. World Health Organization. https://apps.who.int/iris/handle/10665/326948. License: CC BY-NC-SA 3.0 IGO. Accessed 25 Oct 2020.

  82. Wolf T, Müller-Oerlinghausen B, Ahrens B, Grof P, Schou M, Felber W, et al. How to interpret findings on mortality of long-term lithium treated manic-depressive patients?! Critique of different methodological approaches. J Affect Disord. 1996;39:127–32.

    Article  CAS  Google Scholar 

  83. Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, et al. Evidence-based national suicide prevention taskforce in Europe: a consensus position paper. Neuropsychopharmacology. 2017;27:418–21.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

    Ute Lewitzka

Authors
  1. Ute Lewitzka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ute Lewitzka .

Editor information

Editors and Affiliations

  1. Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy

    Maurizio Pompili

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Lewitzka, U. (2022). Anti-suicidal Properties of Lithium Treatment. In: Pompili, M. (eds) Suicide Risk Assessment and Prevention. Springer, Cham. https://doi.org/10.1007/978-3-030-42003-1_68

Download citation

Publish with us

Policies and ethics

Search

Navigation